First-in-human feasibility study of a portable low-field pulsed-gradient-free MR device in acute stroke
Year: 2026
Type: article
Abstract: We conducted the first-in-human evaluation of a novel portable low-field 0.1 T pulsed-gradient-free magnetic resonance (MR) device (~ 100 kg) that acquires regional MR biomarkers for bedside stroke assessment. We aimed to evaluate its safety, tolerability and feasibility in acute stroke. This single-centre non-randomised observational cohort study prospectively recruited healthy controls and consecutive stroke patients within 72-h of hospital presentation. Participants underwent conventional 1.5–3 T MRI and two consecutive device scans (DWI, T2). The primary outcomes were feasibility with the proportion of scans where an interpretable signal-to-noise ratio (SNR) was obtained, safety, and tolerability via survey. Forty of forty-nine participants with acute stroke (34 ischemic and 6 hemorrhagic) had successful scans; median age 71 (years[IQR 58.5–76.5]); median NIHSS 4.5 [IQR 2.0–12.0]) and 20 healthy controls were enrolled. No device-related safety concerns were identified, and the scanner was generally well tolerated. SNR ≥ 3 for algorithm-based analysis were obtained in 36/40 (90.0%) stroke participants and 12/40 (30.0%) achieved the higher threshold for heatmap visualisation (SNR ≥ 12). This first-in-human study demonstrates the safety, tolerability, and technical feasibility of operating the device within an inpatient stroke workflow and generate interpretable MR-derived signals in most patients. These findings justify larger prospective studies to evaluate diagnostic performance and clinical implementation.
Source: Scientific Reports
Authors: James L. Barker(Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing), Yu-Chieh Tzeng, Paul D. Teal(Formal analysis, Methodology, Writing – original draft, Writing – review & editing), Dion Thomas(Formal analysis, Methodology, Writing – review & editing), Leonid Churilov(Formal analysis), Amy McDonald(Data curation, Investigation), Tyson Moed(Data curation, Investigation), Samantha Rivet(Investigation, Writing – review & editing), Oshi Swarup(Investigation, Writing – review & editing), Peter Anderyas(Investigation, Writing – review & editing), Sean Pierce(Formal analysis, Methodology, Writing – review & editing), Flynn Stilwill(Formal analysis, Methodology, Writing – review & editing), Laura Mulligan(Formal analysis, Methodology, Writing – review & editing), Sergei Obruchkov(Conceptualization, Formal analysis, Methodology, Writing – review & editing), Kern Cowell(Formal analysis, Methodology, Writing – review & editing), Javier M. Romero, Anne W. Alexandrov, Andrei V. Alexandrov, Joshua N. Goldstein(Formal analysis), Osama O. Zaidat(Formal analysis), David S. Liebeskind, Gerard Loquet(Formal analysis, Methodology, Writing – review & editing), Mark Parsons(Funding acquisition, Supervision, Writing – review & editing), Bruce C. V. Campbell(Supervision, Writing – review & editing), Geoffrey A. Donnan(Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Writing – review & editing), Stephen M. Davis(Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Supervision, Writing – review & editing)
Institutions: The Royal Melbourne Hospital, The University of Melbourne, Harvard University, Massachusetts General Hospital, University of Tennessee Health Science Center, University of Arizona College of Medicine- Phoenix, Mercy St. Vincent Medical Center, Mercy Health, University of Southern California, Keck Hospital of USC, The University of Sydney, Westmead Hospital
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W7235864050
